|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.80 EUR | +5.16% |
|
+4.61% | -17.11% |
| Feb. 24 | Wedbush Initiates Abivax at Underperform With $110 Price Target | MT |
| Feb. 23 | Abivax Shows Jitters Despite Promising Updates on Obefazimod |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABIVAX | Other Biotechnology & Medical Research | +5.16% | +4.61% | -17.11% | +1,528.06% | +372.99% | 8.56B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
